LivaNova PLC (NasdaqGS: LIVN)
Health Care · Health Care Equipment & Supplies · GB
$78.74
-4.23% today · +40.9% 1Y
LivaNova PLC (NasdaqGS: LIVN) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $4.34B and employs 3,300 people.
Over the last twelve months the share price has gained 40.9%, trading between 48.82 and 85.76.
Tweenvest scores LivaNova PLC across four factors: quality 76/100, value 41/100, growth 71/100. Its strongest factor is quality.
LIVN price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $4.34B
- Revenue (TTM)
- $1.47B
- P/E
- 23.15
- EPS
- 3.40
- Dividend yield
- —
- Beta (5Y)
- 0.87
- 52-week high
- $85.76
- 52-week low
- $48.82
- Avg volume (3M)
- —
- Shares outstanding
- 55.09M
- Employees
- 3,300
- Next earnings
- —
About LivaNova PLC
LivaNova PLC is a global medical technology company dedicated to developing, manufacturing, and marketing a variety of therapeutic solutions. The company operates through three key segments. Its Cardiopulmonary division provides essential products for heart-lung procedures, such as oxygenators, heart-lung machines, and various perfusion systems. The Neuromodulation segment is known for its VNS Therapy System, an implantable device that delivers vagus nerve stimulation to treat drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea. This segment is also advancing the VITARIA System, which employs VNS for heart failure, through clinical development. The Advanced Circulatory Support segment offers temporary life support solutions, including both cardiopulmonary and respiratory support technologies. LivaNova serves a wide range of medical professionals, including perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals and healthcare providers. The company's products are distributed globally through both its direct sales force and independent distributors. Additionally, LivaNova has a research collaboration with Verily aimed at discovering clinical biomarkers for depression. Founded in 1987, the company is headquartered in London, United Kingdom.
- Founded
- 2015
- Listed since
- Oct 19, 2015
- Exchange
- Nasdaq Global Select
- Currency
- USD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Abbott LaboratoriesNYSE: ABT | $201.83B | $116.64 | +2.19% |
| Intuitive Surgical, Inc.NasdaqGS: ISRG | $133.83B | $378.81 | +1.19% |
| Stryker CorporationNYSE: SYK | $126.37B | $329.45 | +0.53% |
| Medtronic plcNYSE: MDT | $119.49B | $93.35 | +1.14% |
| EssilorLuxottica Société anonymeENXTPA: EL | $87.56B | €163.20 | +1.24% |
| Boston Scientific CorporationNYSE: BSX | $73.00B | $50.37 | +2.03% |
| HOYA CorporationTSE: 7741 | $52.38B | ¥24,895.00 | -1.37% |
| Becton, Dickinson and CompanyNYSE: BDX | $52.30B | $192.00 | +2.33% |
Figures last refreshed Aug 18, 2026.